Cristof Westenfelder
Directeur Général chez SymbioCellTech LLC
Profil
Cristof Westenfelder is the founder of SymbioCellTech LLC, founded in 2006, where he holds the title of Chief Executive Officer & Chairman.
He was also the founder of AlloCure, Inc., founded in 2008, where he held the title of Chief Medical Officer from 2008 to 2010.
Dr. Westenfelder's former job was as a Professor at the University of Utah.
Postes actifs de Cristof Westenfelder
| Sociétés | Poste | Début |
|---|---|---|
SymbioCellTech LLC
 SymbioCellTech LLC BiotechnologyHealth Technology SymbioCellTech LLC engages in biotechnology company. It develops treatment to reduce or elimininate the need for external insulin therapy in insulin-dependent diabetes. The company was founded by Christof Westenfelder and Axel Zander in 2006 and is headquartered in Salt Lake, UT. | Directeur Général | 01/01/2006 |
Anciens postes connus de Cristof Westenfelder
| Sociétés | Poste | Fin |
|---|---|---|
| University of Utah | Corporate Officer/Principal | - |
AlloCure, Inc.
 AlloCure, Inc. BiotechnologyHealth Technology AlloCure, Inc. develops cell therapies for the treatment of kidney diseases. It engages in developing allogeneic mesenchymal stem cell therapy for acute kidney injury. The company was founded in 2008 and is headquartered in Burlington, MA. | Fondateur | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
AlloCure, Inc.
AlloCure, Inc. BiotechnologyHealth Technology AlloCure, Inc. develops cell therapies for the treatment of kidney diseases. It engages in developing allogeneic mesenchymal stem cell therapy for acute kidney injury. The company was founded in 2008 and is headquartered in Burlington, MA. | Health Technology |
SymbioCellTech LLC
SymbioCellTech LLC BiotechnologyHealth Technology SymbioCellTech LLC engages in biotechnology company. It develops treatment to reduce or elimininate the need for external insulin therapy in insulin-dependent diabetes. The company was founded by Christof Westenfelder and Axel Zander in 2006 and is headquartered in Salt Lake, UT. | Health Technology |
